Suppr超能文献

追寻反馈激活:氧化应激防治中关于氧化还原响应型氢过硫化物前药的新见解。

In pursuit of feedback activation: New insights into redox-responsive hydropersulfide prodrug combating oxidative stress.

机构信息

Key Laboratory of Drug Metabolism and Pharmacokinetics, Haihe Laboratory of Cell Ecosystem, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing, 210009, Jiangsu, China.

Key Laboratory of Drug Metabolism and Pharmacokinetics, Haihe Laboratory of Cell Ecosystem, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing, 210009, Jiangsu, China.

出版信息

Redox Biol. 2024 Jun;72:103130. doi: 10.1016/j.redox.2024.103130. Epub 2024 Mar 21.

Abstract

Redox-responsive hydropersulfide prodrugs are designed to enable a more controllable and efficient hydropersulfide (RSSH) supply and to thoroughly explore their biological and therapeutic applications in oxidative damage. To obtain novel activation patterns triggered by redox signaling, we focused on NAD(P)H: quinone acceptor oxidoreductase 1 (NQO1), a canonical antioxidant enzyme, and designed NQO1-activated RSSH prodrugs. We also performed a head-to-head comparison of two mainstream structural scaffolds with solid quantitative analysis of prodrugs, RSSH, and metabolic by-products by LC-MS/MS, confirming that the perthiocarbamate scaffold was more effective in intracellular prodrug uptake and RSSH production. The prodrug was highly potent in oxidative stress management against cisplatin-induced nephrotoxicity. Strikingly, this prodrug possessed potential feedback activation properties by which the delivered RSSH can further escalate the prodrug activation via NQO1 upregulation. Our strategy pushed RSSH prodrugs one step further in the pursuit of efficient release in biological matrices and improved druggability against oxidative stress.

摘要

氧化还原响应型巯基供体前药旨在提供更可控和有效的巯基(RSSH)供应,并深入探索其在氧化损伤中的生物学和治疗应用。为了获得由氧化还原信号触发的新型激活模式,我们专注于烟酰胺腺嘌呤二核苷酸(磷酸):醌氧化还原酶 1(NQO1),一种典型的抗氧化酶,并设计了 NQO1 激活的 RSSH 前药。我们还通过 LC-MS/MS 对两种主流结构支架进行了头对头比较,并对前药、RSSH 和代谢副产物进行了定量分析,证实了硫代氨基甲酸酯支架在细胞内前药摄取和 RSSH 生成方面更有效。该前药在对抗顺铂诱导的肾毒性的氧化应激管理中非常有效。引人注目的是,该前药具有潜在的反馈激活特性,通过 NQO1 上调,递送至细胞内的 RSSH 可以进一步增强前药的激活。我们的策略在追求在生物基质中有效释放和改善氧化应激药物治疗方面使 RSSH 前药向前迈进了一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e2b/10973683/05c710b02e4c/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验